Multiple studies have found the neutrophil to lymphocyte ratio (NLR) to be associated with
adverse breast cancer (BC) prognosis and survival. Very limited data exist on the role of …

Background Increasing attention is focused on the relationship of inflammation biomarkers
with malignant tumors. The purpose of the present study was to detect whether the …

Response to neoadjuvant chemotherapy in breast cancer patients is of prognostic value in
determining short-and mid-term outcomes. Inflammatory biomarkers, such as platelet-to …

Platelet-lymphocyte ratio (PLR) is a hematological parameter which is investigated as a
biomarker for prognosis in patients with breast cancer. Due to the controversial results from …

Breast cancer is one of the leading malignant tumors that endanger women's health
worldwide. Despite the rapid progress on the therapies, including chemotherapy, surgical …

Background: The objective of this study was to assess the prognostic value of pretreatment
platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to …

Platelets play a multifaceted role in cancer progression and metastasis. Mean platelet
volume (MPV) and platelet distribution width (PDW) are commonly used platelet parameters …

Exploring the potential association between peripheral blood leukocyte counts and breast
cancer risk by Mendelian randomization (MR) analysis methods. Genetic data related to …

Triple negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic
options. New opportunities are emerging from current comprehensive characterization of …

Background: Breast cancer is the most common cancer diagnosis among women worldwide.
It accounts for 25% of all women's cancers. This cancer is invasive with a high mortality rate …